IBEC participates in the First Biennial Ciutat-Ciència 2019

IBEC is a driving force behind a major science festival that will be taking place across the city this year. The event was presented yesterday at a press conference held at the Amfiteatre Anatòmic de la Reial Acadèmia de Medicina and it is organized by the Ajuntament de Barcelona along with other top research centers.
An initiative promoted by the Institut de Cultura de Barcelona (ICUB), Ciutat-Ciència is being planned by a committee of seven reseachers, including IBEC’s group leader Nuria Monstserrat.
With a week of concentrated activity from 7th-11th February, Ciutat-Ciència will present today’s rapidly accelerating scientific advances to citizens and encourage debate and opinion.

IBEC group leader Silvia Muro has been granted funding in MINECO’s ‘Explora Ciencia’ and ‘Explora Tecnología’ 2017 call.
The biotechnology company Iproteos, IBEC and the Vall d’Hebron Research Institute (VHIR) are set to develop an innovative treatment to slow down, stop and even reverse the growth of solid tumors, which represent more than 90% of cancer cases.
This year an IBEC project has won the Fira Recerca en Directe 2019’s public poll for most popular project, with 26.94% of the votes.
The nanoBio&Med2018 International Conference opened today with IBEC Director Josep Samitier chairing the first round of talks, in which group leader Samuel Sanchez is the first speaker.
Today Spain’s Severo Ochoa Centres of Excellence – including IBEC – and the María de Maeztu Units of Excellence are at the CNIO in Madrid for 100xCiencia.3, the annual event of the
IBEC researchers were in the limelight today at the awards ceremony for the “la Caixa” fellowships and grants for research and innovation calls.
Projects led by IBEC group leader Xavier Fernandez-Busquets and Associated Researcher Antonio Juarez have received funds from 2017’s La Marató de TV3 fundraising campaign.